SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this

被引:0
|
作者
Soh, B. W. T. [1 ]
Balfe, C. [1 ]
O'Brien, K. [1 ]
Glasgow, J. [1 ]
Forkin, A. [1 ]
Sim, W. H. [1 ]
Muradagha, H. [1 ]
Abbas, S. [1 ]
Arnous, S. [1 ]
Kiernan, T. [1 ]
机构
[1] Univ Hosp Limerick, Limerick, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:952 / 952
页数:1
相关论文
共 50 条
  • [21] Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction
    Romeo, Francisco J.
    Del Buono, Marco G.
    Aguilar-gallardo, Jose S.
    Lorente-ros, Marta
    Damonte, Juan I.
    Chiabrando, Juan G.
    Dixon, Dave L.
    Biondi-zoccai, Giuseppe
    Abbate, Antonio
    Carbone, Salvatore
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (01) : 95 - 97
  • [22] STRATEGIES TO OPTIMISE GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION BY IMPROVING SGLT2I INITIATION RATES IN NURSE-LED OUTPATIENT HEART FAILURE CLINICS
    Soh, Bwt
    Cusack, R.
    O'Brien, K.
    Glasgow, J.
    Forkin, A.
    Abbas, S.
    Arnous, S.
    Kiernan, T.
    HEART, 2022, 108 : A51 - A53
  • [23] Could sweet pee be the answer? Applicability of use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF)
    Sharma, A.
    Lakra, O.
    Al-Dulaimi, Z.
    Sethi, J.
    Shah, J.
    Hui, E.
    DIABETIC MEDICINE, 2021, 38
  • [24] Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction
    Suzuki, Atushi
    Tomari, Erina
    Shiga, Tsuyoshi
    Sakai, Msayuki
    Osada, Akihiro
    Kikuchi, Noriko
    Hagiwara, Nobuhisa
    CIRCULATION, 2019, 140
  • [25] Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
    Kim, Hyue Mee
    Hwang, In-Chang
    Choi, Wonsuk
    Yoon, Yeonyee E.
    Cho, Goo-Yeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] SGLT2 inhibition in heart failure with reduced or preserved ejection fraction: Finding the right patients to treat
    Girerd, Nicolas
    Zannad, Faiez
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (05) : 550 - 558
  • [27] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
    Mariana Tinoco, M.
    Cardoso, F.
    Dias, G.
    Pereira, T.
    Faria, B.
    Almeida, F.
    Leite, S.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 112 - 112
  • [28] Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
    Hyue Mee Kim
    In-Chang Hwang
    Wonsuk Choi
    Yeonyee E. Yoon
    Goo-Yeong Cho
    Scientific Reports, 11
  • [29] A CASE OF METABOLIC ACIDOSIS AFTER INITIATION OF SGLT2-I THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    D'Errico, G.
    Orso, F.
    Verga, F.
    Salucci, C.
    Perini, E.
    Vatri, M.
    Poletti, E.
    Cagnoni, C.
    Corti, G.
    Di Bari, M.
    Ungar, A.
    Baldasseroni, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [30] SGLT-2 inhibitors in the treatment of heart failure with reduced ejection fraction: a systematic review
    Paffer, Pedro Toscano
    Bezerra de Albuquerque Cortez, Isabelly Regina
    Damasso Lisboa Costa, Marcelo Danilo
    da Costa Neta, Maria Rosalia
    Tavares Pedroza Monteiro, Marina Lins
    Paffer, Matheus Toscano
    Terra Lopes, Vitoria Maria
    de Paffer Filho, Silvio Hock
    AMERICAN HEART JOURNAL, 2021, 242 : 167 - 167